Suzuki Daijiro, Suzuki Takanori, Fujino Masayuki, Asai Yumiko, Kojima Arisa, Uchida Hidetoshi, Saito Kazuyoshi, Kusuki Hirofumi, Li Yuanying, Yatsuya Hiroshi, Sadanaga Tsuneaki, Hata Tadayoshi, Yoshikawa Tetsushi
Department of Pediatrics, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Clinical Laboratory, JCHO-Chukyo Hospital, Nagoya, Aichi, Japan.
Fujita Med J. 2023 Nov;9(4):275-281. doi: 10.20407/fmj.2023-001. Epub 2023 Aug 28.
The Gunma score is used to predict the severity of Kawasaki disease (KD), including coronary artery aneurysm (CAA) as a cardiac complication, in Japan. Additionally, the characteristic ratio of ventricular repolarization (T-peak to T-end interval to QT interval [Tp-e/QT]) on a surface electrocardiogram reflects myocardial inflammation. This study aimed to determine whether the Tp-e/QT can be used to predict CAA in children with KD.
We analyzed chest surface electrocardiograms of 112 children with KD before receiving intravenous immunoglobulin therapy using available software (QTD; Fukuda Denshi, Tokyo, Japan).
The Tp-e/QT (lead V5) was positively correlated with the Gunma score (r=0.352, p<0.001). The Tp-e/QT was larger in patients with CAA (residual CAA at 1 month after onset) than in those without CAA (0.314±0.026 versus 0.253±0.044, p=0.003). A receiver operating characteristic curve analysis was performed to assess whether the Gunma score and Tp-e/QT could predict subsequent CAA. The area under the curve of the Gunma score was 0.719 with the cutoff set at 5 points. The area under the curve of the Tp-e/QT was 0.892 with a cutoff value of 0.299. The fit of the prediction models to the observed probability was tested by the Hosmer-Lemeshow test with calibration plots using Locally weighted scatterplot smoothing (LOESS) fit. The Gunma score (p=0.95) and Tp-e/QT (p=0.95) showed a good fit.
The Tp-e/QT is a useful biomarker in predicting coronary aneurysm complications in KD.
在日本,群马评分用于预测川崎病(KD)的严重程度,包括作为心脏并发症的冠状动脉瘤(CAA)。此外,体表心电图上心室复极的特征性比值(T波峰至T波终末间期与QT间期的比值[Tp-e/QT])反映心肌炎症。本研究旨在确定Tp-e/QT是否可用于预测KD患儿的CAA。
我们使用可用软件(QTD;日本东京福田电子)分析了112例接受静脉注射免疫球蛋白治疗前的KD患儿的胸部体表心电图。
Tp-e/QT(V5导联)与群马评分呈正相关(r = 0.352,p < 0.001)。CAA患者(发病后1个月残留CAA)的Tp-e/QT大于无CAA患者(0.314±0.026对0.253±0.044,p = 0.003)。进行了受试者工作特征曲线分析,以评估群马评分和Tp-e/QT是否能预测随后的CAA。群马评分的曲线下面积为0.719,截断值设定为5分。Tp-e/QT的曲线下面积为0.892,截断值为0.299。通过使用局部加权散点图平滑(LOESS)拟合的校准图的Hosmer-Lemeshow检验来测试预测模型与观察概率的拟合度。群马评分(p = 0.95)和Tp-e/QT(p = 0.95)显示拟合良好。
Tp-e/QT是预测KD冠状动脉瘤并发症的有用生物标志物。